**Core Concept:** Serum lithium levels play a crucial role in monitoring the therapeutic response and preventing toxicity in patients on lithium therapy for the management of bipolar disorder. Lithium is a neuroprotective agent that stabilizes neuronal function and reduces manic episodes.

**Why the Correct Answer is Right:** In the context of bipolar disorder management, maintaining serum lithium levels between 0.6-1.2 mEq/L is crucial. The therapeutic range ensures optimal neuroprotective effects without causing toxicity symptoms. This range is based on the balance between minimizing side effects and achieving therapeutic efficacy.

**Why Each Wrong Option is Incorrect:**

A. **Too low (0.4 mEq/L):** This option is incorrect because lithium's therapeutic effects are minimal, leading to an inadequate response in patients.

B. **Too high (1.5 mEq/L):** This option is incorrect because lithium toxicity occurs at levels above 1.5 mEq/L, presenting with symptoms like tremors, nausea, vomiting, muscle weakness, and impaired renal function.

C. **Uncertain (0.8 mEq/L):** This option is not a definitive answer because the exact therapeutic range is between 0.6-1.2 mEq/L, not including 0.8 mEq/L.

D. **Incorrect therapeutic range (0.9 mEq/L):** This option is incorrect because the correct therapeutic range is 0.6-1.2 mEq/L, not 0.9 mEq/L.

**Clinical Pearl:** Regular monitoring of serum lithium levels is essential in managing bipolar disorder patients on lithium therapy. Adjusting dosing intervals according to the observed levels helps maintain therapeutic efficacy and reduce toxicity risks. Potential side effects include nephrogenic diabetes insipidus, tremors, ataxia, tremors, and lithium-induced nephrogenic diabetes insipidus.

**Correct Answer:** D. 0.6-1.2 mEq/L

---

---

---

---